News

Hims & Hers (NYSE:HIMS) stock slips as U.S. lawmakers seek FDA action against copycat versions of weight loss drugs from Novo ...
After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...
A young woman details her experience with the newly available weight loss medication.
A woman on Ozempic has revealed why she gave her 11 year old daughter weight loss jabs, a similar drug called Wegovy, on This ...
HIMS stock up 16% on Wednesday, continuing month-long gains. Novo Nordisk ends partnership, cites misleading marketing and safety concerns.
Tears Pour In for Sheryl Swoopes After Sharing Life-Changing Event originally appeared on Athlon Sports. WNBA legend Sheryl ...
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.
Novo Nordisk announced it is cutting ties with telehealth giant Hims & Hers Health, pulling its blockbuster drug Wegovy from ...
Novo Nordisk just pulled Wegovy from a major telehealth platform over safety concerns about knockoff versions. Here's what ...
Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...
Many people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to ...
The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But ...